[{"NetIncomeLoss_1_Q2_USD":-16380000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":19914000.0,"Depreciation_1_Q2_USD":292000.0,"Depreciation_2_Q2_USD":578000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1683000.0,"InventoryFinishedGoods_0_Q2_USD":6533000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":388000.0,"DerivativeLiabilitiesCurrent_0_Q2_USD":963000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":2606000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":2825000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3278000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":6413000.0,"OperatingLeaseLiability_0_Q2_USD":960000.0,"EquityMethodInvestments_0_Q2_USD":41000.0,"NotesIssued1_2_Q2_USD":133000.0,"FinanceLeaseLiability_0_Q2_USD":9000.0,"Liabilities_0_Q2_USD":8127000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":19914000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":199941000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":2606000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":19914000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q2_USD":740000.0,"ShareBasedCompensation_2_Q2_USD":2258000.0,"Assets_0_Q2_USD":113970000.0,"CommonStockSharesIssued_0_Q2_shares":25982367.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":8000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":293000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":783000.0,"SellingAndMarketingExpense_1_Q2_USD":1366000.0,"SellingAndMarketingExpense_2_Q2_USD":2942000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":4499000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":9067000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":284000.0,"AssetsCurrent_0_Q2_USD":46254000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":39000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":116000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":706000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":null,"IncomeTaxExpenseBenefit_2_Q2_USD":null,"AccountsReceivableNetCurrent_0_Q2_USD":4351000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":177000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":23292635.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":27013580.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":2825000.0,"EarningsPerShareBasic_1_Q2_USD":-0.7,"EarningsPerShareBasic_2_Q2_USD":0.23,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":2472000.0,"InventoryRawMaterials_0_Q2_USD":2679000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":999000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":1477000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":3140000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":82600.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":440000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q2_USD":13000.0,"CommonStockValue_0_Q2_USD":26000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":29879000.0,"DepositsAssetsNoncurrent_0_Q2_USD":36000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":973000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":1394000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":63000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":5093000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-16380000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-82000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":16442000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":-5472000.0,"DeferredCompensationLiabilityCurrent_0_Q2_USD":1813000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":10000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":2175000.0,"CostsAndExpenses_1_Q2_USD":9876000.0,"CostsAndExpenses_2_Q2_USD":21668000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":-1463000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-1526000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":483000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":20224000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":55000.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q2_USD":238000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":414000.0,"NonoperatingIncomeExpense_1_Q2_USD":-16424000.0,"NonoperatingIncomeExpense_2_Q2_USD":5514000.0,"AccountsPayableCurrent_0_Q2_USD":3077000.0,"LiabilitiesCurrent_0_Q2_USD":7490000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":559000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_2_Q2_USD":0.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":null,"InventoryWorkInProcess_0_Q2_USD":1678000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":23292635.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":22151726.0,"ProceedsFromWarrantExercises_2_Q2_USD":24000.0,"RepaymentsOfDebt_2_Q2_USD":2175000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":4890000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1145000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":2258000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-16380000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":5928000.0,"InterestExpense_2_Q2_USD":1000.0,"Goodwill_0_Q2_USD":33506000.0,"InterestExpense_1_Q2_USD":null,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":20588000.0,"NetIncomeLoss_2_Q2_USD":5928000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5347000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-14000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":388000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":29000.0,"OperatingLeasePayments_1_Q2_USD":217000.0,"OperatingLeasePayments_2_Q2_USD":434000.0,"NumberOfOperatingSegments_2_Q2_pure":1.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":20588000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":4.75,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":29879000.0,"StockIssued1_2_Q2_USD":314000.0,"ShortTermLeaseCost_1_Q2_USD":59000.0,"ShortTermLeaseCost_2_Q2_USD":117000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-16380000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":350000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.065,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1134000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.081,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":0.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":8439000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":null,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1145000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2258000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":113970000.0,"OperatingLeaseCost_2_Q2_USD":339000.0,"OperatingLeaseCost_1_Q2_USD":170000.0,"PreferredStockValue_0_Q2_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":23060000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":286000.0,"InvestmentIncomeInterest_1_Q2_USD":18000.0,"InvestmentIncomeInterest_2_Q2_USD":47000.0,"InventoryNet_0_Q2_USD":10890000.0,"OtherNonoperatingExpense_1_Q2_USD":null,"OtherNonoperatingExpense_2_Q2_USD":4000.0,"OperatingIncomeLoss_1_Q2_USD":44000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":844000.0,"AccountsPayableOtherCurrent_0_Q2_USD":206000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":1412000.0,"OtherLiabilitiesCurrent_0_Q2_USD":17000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3092000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":2795000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":2770000.0,"EarningsPerShareDiluted_2_Q2_USD":0.01,"EarningsPerShareDiluted_1_Q2_USD":-0.7,"CommonStockSharesOutstanding_0_Q2_shares":25982367.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-924000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":23431000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-94124000.0,"VariableLeaseCost_1_Q2_USD":0.0,"VariableLeaseCost_2_Q2_USD":0.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":22082000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":9920000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-467000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":251000.0,"StockholdersEquity_0_Q2_USD":105843000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":133000.0,"GoodwillPurchaseAccountingAdjustments_2_Q2_USD":-131000.0,"Ticker":"BLFS","CIK":"834365","name":"BIOLIFE SOLUTIONS INC","OfficialName":"BioLife Solutions Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"708458227.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]